Search results
Results From The WOW.Com Content Network
The book examines how major pharmaceutical companies determine which health care problems are publicised and researched. [1] Outlining the history of the pharmaceutical industry, Law identifies what she says is the failure of a regulatory framework that assumes pharmaceutical companies always produce worthwhile products that society will want. [1]
The Federal Trade Commission had its first win earlier this week in its crusade to block drug company deals: Sanofi on Monday ended its up-to-$735 million licensing deal with Maze Therapeutics.
AstraZeneca claimed the deal undervalued the company. [15] 4 2014 Pfizer: Astra Zeneca: 99 127 AstraZeneca claimed the deal undervalued the company. [16] 5 1999 Pfizer: Warner–Lambert: 82.4 151 Pfizer made a hostile bid, just after the announcement of a $72 billion deal with Wyeth, the eventual purchase price would be in excess of $90 billion ...
The Cathay Drug Company operates exclusively in the Philippines. Its main area of specialization is the marketing and distribution of pharmaceutical drugs and products for both humans and animals. The company acquires its products through licensing agreements with domestic and international firms. Among its main suppliers are the following:
He goes on to consider that overblown attacks on "Big Pharma" actually let the pharmaceutical industry "off the hook" since they distract from and tarnish more considered criticisms. [5] He has also written, on Skepticblog , about the general misunderstanding and sensationalizing of cancer research that typically accompanies a conspiratorial ...
On average, it takes over a decade and $2.3 billion for a pharmaceutical company to develop a new medication, an expensive slog that few companies want to risk tinkering with. Introducing a new ...
The following table lists the largest biotechnology and pharmaceutical companies ranked by revenue in billion USD. The change column indicates the company's relative position in this list compared to its relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.
Deadly Medicines and Organised Crime: How Big Pharma Has Corrupted Healthcare is a book by Peter C. Gøtzsche with forewords by Richard Smith and Drummond Rennie. It was published by Taylor & Francis in 2013. The book says that activities by major pharmaceutical companies include corruption, fraud, bribery, and omission of data to market their ...